SG is a biotechnology company that provides drug development and laboratory testing services for pharmaceutical and chemical industries... Read more
SG is a biotechnology company that provides drug development and laboratory testing services for pharmaceutical and chemical industries... Read more
Est. Annual Revenue
<$1M
Est. Employees
<10
News
Mar 03, 2021
GlobalNewswire
Press Release: Salzman Group : Claritas (formerly Kalytera Therapeutics, Inc.) to Collaborate with Salzman Group and Other Companies to Accelerate Development of R-107 for Treatment of Vaccine-Resistant COVID-19, Influenza, and Other Viral Infections
Jul 16, 2020
Benzinga
Salzman Group: Kalytera Announces Exclusive License Agreement with Salzman Group for Development and Commercialization of R-107 for Treatment of Coronavirus and COVID-19 Infection
Jun 30, 2020
Benzinga
Salzman Group: Kalytera Provides Updates Regarding Annual Filings, the Acquisition of Salzman Group, and the Company's Private Placement
Jun 16, 2020
Benzinga
Salzman Group: Kalytera Provides Update Regarding Acquisition of Salzman Group
May 19, 2020
Seeking Alpha
Salzman Group: Kalytera to acquire owner of lung disease candidate
May 19, 2020
Benzinga
Salzman Group: Kalytera Announces Binding Agreement to Acquire Salzman Group
Feb 20, 2020
StreetInsider
Press Release: Salzman Group : Kalytera Announces Modification to Sale Period for Shares Issued under Payments Agreement
Feb 08, 2020
Unique Finance
Salzman Group: Kalytera Announces New Payments Agreement with the Salzman Group of Israel
Mar 01, 2019
BioPortfolio
Salzman Group: Life Science Big News Roundup Kalytera Announces Share Issuance Under Payments Agreements with Salzman Group; BriaCell Announces C$500000 Equity Investment by BriaCell Director
Jan 15, 2019
CENTRALCHARTS
Press Release: Salzman Group : Kalytera Announces Share Issuance and Extension to March 1 under Payments Agreements with Salzman Group